Sino Biological,Inc. Cash Flow Statement

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022
Net Income	147.74	121.93	260.13	302.96	720.01
Depreciation & Amortization	91.18	90.53	69.21	37.61	25.8
Other Amortization	10.09	10.17	8.71	6.2	10.17
Loss (Gain) From Sale of Assets	-0.54	0.35	-0.05	-0.21	0.01
Asset Writedown & Restructuring Costs	-21.01	-	-	-	15.51
Loss (Gain) From Sale of Investments	-59.95	-90.2	-100.32	-54.15	-74.32
Provision & Write-off of Bad Debts	-	8.26	11.05	0.26	-
Other Operating Activities	10.01	6.26	15.8	-16.2	-9.13
Change in Accounts Receivable	-26.14	-20.79	83.15	21.01	26.66
Change in Inventory	-20.47	14.39	-21.94	-32.98	-17.73
Change in Accounts Payable	11.95	-9.72	16.66	8.06	-74.04
Change in Other Net Operating Assets	0.44	0.77	2.7	1.8	4.34
Operating Cash Flow	146.19	113.73	322.56	249.39	642.62
Operating Cash Flow Growth	28.54%	-64.74%	29.34%	-61.19%	-41.20%
Capital Expenditures	-101.05	-69.95	-1,043	-156.06	-47.9
Sale of Property, Plant & Equipment	0.67	-	0.03	-	-
Cash Acquisitions	-50.35	-285.05	-	-	-
Investment in Securities	506.27	-167.18	-220.75	-19.51	-2,541
Other Investing Activities	76.7	86.28	76.1	111.42	40.31
Investing Cash Flow	432.24	-435.91	-1,188	-64.15	-2,549
Long-Term Debt Repaid	-	-30.88	-31.35	-24.11	-28.3
Total Debt Repaid	-	-30.88	-31.35	-24.11	-28.3
Net Debt Issued (Repaid)	-	-30.88	-31.35	-24.11	-28.3
Issuance of Common Stock	-	-	-	-	4,741
Repurchase of Common Stock	-	-453.14	-	-	-
Common Dividends Paid	-608.18	-255.52	-258.4	-680	-
Other Financing Activities	-31.21	-0.1	-0.22	-0.16	-
Financing Cash Flow	-639.39	-739.64	-289.97	-704.27	4,712
Foreign Exchange Rate Adjustments	0.62	-0.41	-6.13	5.13	0.92
Net Cash Flow	-60.35	-1,062	-1,162	-513.89	2,807
Free Cash Flow	45.14	43.78	-720.8	93.34	594.72
Free Cash Flow Growth	3.10%	-	-	-84.31%	-44.66%
Free Cash Flow Margin	6.45%	7.13%	-111.51%	16.24%	61.61%
Free Cash Flow Per Share	0.37	0.34	-5.58	0.82	5.52
Cash Income Tax Paid	54.15	45.53	-0.06	88.22	208.51
Levered Free Cash Flow	-16.83	72.87	-871.24	28.46	364.82
Unlevered Free Cash Flow	-16.83	75.36	-868.91	30.2	366.07
Change in Working Capital	-31.34	-33.57	58.04	-27.06	-45.42

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.